Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinology 2021 June;46(2) > Minerva Endocrinology 2021 June;46(2):177-92

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  OBESITY: A SPOTLIGHT ON THERAPEUTIC APPROACHES 

Minerva Endocrinology 2021 June;46(2):177-92

DOI: 10.23736/S2724-6507.20.03299-X

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Vitamin D in obesity and obesity-related diseases: an overview

Luigi BARREA 1, 2 , Evelyn FRIAS-TORAL 3, 4, Gabriella PUGLIESE 1, 2, Eloisa GARCIA-VELASQUEZ 5, Maria DE LOS ANGELES CARIGNANO 6, Silvia SAVASTANO 1, 2, Annamaria COLAO 1, 2, 7, Giovanna MUSCOGIURI 1, 2

1 Unit of Endocrinology, Department of Clinical Medicine and Surgery, Collaborating Centers for Obesity Management (COM) of The European Association for the Study of Obesity (EASO), Federico II University Medical School of Naples, Naples, Italy; 2 Unit of Endocrinology, Department of Clinical Medicine and Surgery, Centro Italiano per la Cura e il Benessere del Paziente con Obesità (C.I.B.O), University Medical School of Naples, Naples, Italy; 3 SOLCA Hospital, Guayaquil, Ecuador; 4 Santiago de Guayaquil Catholic University, Guayaquil, Ecuador; 5 Clinical Nutrition Service, San Francisco Clinic Hospital, Guayaquil, Ecuador; 6 Section of Nutritional Support, Italian Hospital of Buenos Aires, Buenos Aires, Argentina; 7 Federico II University, Naples, Italy



Hypovitaminosis D and obesity represent two pandemic conditions sometimes associated with each other. Although it is known that there is a close relationship between these two health problems, the underlying pathophysiological mechanism has not yet been fully clarified. In fact, on the one hand, obesity per se seems to involve low circulating levels of vitamin D due to low sun exposure, physical activity, and intake of foods rich in vitamin D, volumetric dilution and sequestration in the adipose tissue. Conversely, since preadipocytes and adipocytes express the receptors and are involved in the metabolism of vitamin D it would seem that low levels of this vitamin may be involved in adipogenesis and therefore in the development of obesity. This connection is extremely important when considering obesity-related diseases. In fact, low vitamin D levels and severe obesity are significantly associated with some cardio-metabolic risk factors, including high Body Mass Index, waist circumference, blood pressure, impaired lipid and glycemic profile and insulin resistance, as they would seem associated with worse cardiovascular outcomes and higher cancer incidence and mortality. Therefore, the purpose of this review was to examine the recent evidence linking low vitamin D status, obesity and obesity-related diseases, highlighting the scientific achievements and the gaps to be filled with further investigations.


KEY WORDS: Obesity; Vitamin D; Cardiovascular diseases; Nutritionists

top of page